In the last 12 months, insiders at Medtronic plc ($MDT) filed 360 transactions with the SEC: 3 open-market purchases totaling $526,186 and 30 sales totaling $17,274,602. Net insider sentiment: net selling.
Medtronic plc operates in the Electromedical & electrotherapeutic apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Martha Geoffrey (Chairman and CEO) — 34 transactions totaling $21,772,549
- KIIL HARRY SKIP (EVP & President Cardiovascular) — 21 transactions totaling $11,392,255
- Wall Brett A. (EVP & Pres Neuroscience) — 33 transactions totaling $6,006,005
- Smith Gregory L (EVP Global Ops & Supply Chain) — 32 transactions totaling $5,981,374
- Salmon Sean (EVP & President Cardiovascular) — 24 transactions totaling $5,470,063
View all SEC Filings for Medtronic plc (MDT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | F | Ordinary Shares | 2976 | $96.71 | 37,574.0000 | 1,288,000,000 | 7.34% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Ordinary Shares | 30568 | $93.08 | 64,984.0000 | 1,288,000,000 | 88.82% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Ordinary Shares | 385 | $80.00 | 85,292.0000 | 1,288,000,000 | 0.45% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Stock Option (Right to Buy) | 30568 | $0.00 | 11,606.0000 | 1,288,000,000 | 72.48% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Stock Option (Right to Buy) | 19923 | $0.00 | 18,926.0000 | 1,288,000,000 | 51.28% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Stock Option (Right to Buy) | 385 | $0.00 | 1,155.0000 | 1,288,000,000 | 25.00% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | Ordinary Shares | 385 | $97.82 | 32,768.0000 | 1,288,000,000 | 1.16% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | Ordinary Shares | 668 | $97.83 | 33,153.0000 | 1,288,000,000 | 1.98% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | Ordinary Shares | 19255 | $97.77 | 33,821.0000 | 1,288,000,000 | 36.28% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | Ordinary Shares | 30568 | $97.66 | 53,076.0000 | 1,288,000,000 | 36.55% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | Ordinary Shares | 1648 | $97.86 | 83,644.0000 | 1,288,000,000 | 1.93% | 0.00% |
| Feb. 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Ordinary Shares | 19923 | $87.76 | 84,907.0000 | 1,288,000,000 | 30.66% | 0.00% |
| Feb. 20, 2026 | Blomquist Denise L. | Chief Accounting Officer | G | Ordinary Shares | 340 | $0.00 | 11,966.0000 | 1,288,000,000 | 2.76% | 0.00% |
| Jan. 29, 2026 | Blomquist Denise L. | Chief Accounting Officer | F | Ordinary Shares | 148 | $101.00 | 12,306.0000 | 1,288,000,000 | 1.19% | 0.00% |
| Dec. 15, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | Ordinary Shares | 1371 | $99.87 | 50,818.0000 | 1,288,000,000 | 2.63% | 0.00% |
| Dec. 15, 2025 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 1564 | $99.87 | 246,393.0000 | 1,288,000,000 | 0.63% | 0.00% |
| Dec. 15, 2025 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 439 | $99.87 | 54,749.0000 | 1,288,000,000 | 0.80% | 0.00% |
| Dec. 5, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | F | Ordinary Shares | 1702 | $101.36 | 34,177.0000 | 1,288,000,000 | 4.74% | 0.00% |
| Nov. 20, 2025 | Blomquist Denise L. | Chief Accounting Officer | G | Ordinary Shares | 170 | $0.00 | 12,357.0000 | 1,288,000,000 | 1.36% | 0.00% |
| Nov. 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 227 | $102.05 | 46,841.0000 | 1,288,000,000 | 0.48% | 0.00% |
| Nov. 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 1995 | $102.03 | 47,893.0000 | 1,288,000,000 | 4.00% | 0.00% |
| Nov. 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 1942 | $101.99 | 49,888.0000 | 1,288,000,000 | 3.75% | 0.00% |
| Nov. 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 24186 | $101.93 | 51,830.0000 | 1,288,000,000 | 31.82% | 0.00% |
| Nov. 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 500 | $102.08 | 46,016.0000 | 1,288,000,000 | 1.07% | 0.00% |
| Nov. 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 325 | $102.06 | 46,516.0000 | 1,288,000,000 | 0.69% | 0.00% |
| Nov. 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 825 | $102.04 | 47,068.0000 | 1,288,000,000 | 1.72% | 0.00% |
| Sept. 3, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | Ordinary Shares | 8405 | $91.58 | 35,815.0000 | 1,289,900,000 | 19.01% | 0.00% |
| Sept. 3, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | S | Ordinary Shares | 200 | $91.59 | 35,615.0000 | 1,289,900,000 | 0.56% | 0.00% |
| Aug. 22, 2025 | Jellison William R | Director | P | Ordinary Shares | 2500 | $92.73 | 2,500.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| Aug. 25, 2025 | Jellison William R | Director | P | Ordinary Shares | 2500 | $92.37 | 5,000.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 20, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | Ordinary Shares | 1052 | $93.22 | 51,939.0000 | 1,289,900,000 | 1.99% | 0.00% |
| Aug. 1, 2025 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 3850 | $89.34 | 54,937.0000 | 1,289,900,000 | 6.55% | 0.00% |
| Aug. 1, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | M | Ordinary Shares | 3126 | $78.00 | 55,855.0000 | 1,289,900,000 | 5.93% | 0.00% |
| Aug. 1, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | Ordinary Shares | 2864 | $89.34 | 52,991.0000 | 1,289,900,000 | 5.13% | 0.00% |
| Aug. 1, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | M | Performance Share Unit | 6535 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | M | Stock Option (Right to Buy) | 3126 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Ordinary Shares | 10457 | $0.00 | 51,775.0000 | 1,289,900,000 | 25.31% | 0.00% |
| Aug. 1, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | F | Ordinary Shares | 4659 | $89.34 | 47,116.0000 | 1,289,900,000 | 9.00% | 0.00% |
| Aug. 1, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | F | Ordinary Shares | 2896 | $89.34 | 44,220.0000 | 1,289,900,000 | 6.15% | 0.00% |
| Aug. 1, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | Performance Share Unit | 10457 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | M | Ordinary Shares | 246 | $0.00 | 12,671.0000 | 1,289,900,000 | 1.98% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | F | Ordinary Shares | 93 | $89.34 | 12,578.0000 | 1,289,900,000 | 0.73% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | M | Ordinary Shares | 58 | $0.00 | 12,636.0000 | 1,289,900,000 | 0.46% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | F | Ordinary Shares | 22 | $89.34 | 12,614.0000 | 1,289,900,000 | 0.17% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | F | Ordinary Shares | 204 | $89.34 | 12,410.0000 | 1,289,900,000 | 1.62% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | M | Ordinary Shares | 214 | $78.00 | 12,624.0000 | 1,289,900,000 | 1.72% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | F | Ordinary Shares | 196 | $89.34 | 12,428.0000 | 1,289,900,000 | 1.55% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | M | Performance Share Unit | 246 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | M | Performance Share Unit | 58 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Blomquist Denise L. | Chief Accounting Officer | M | Stock Option (Right to Buy) | 214 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Walter Matthew R. | SVP, Chief HR Officer | M | Ordinary Shares | 2179 | $0.00 | 32,804.0000 | 1,289,900,000 | 7.12% | 0.00% |
| Aug. 1, 2025 | Walter Matthew R. | SVP, Chief HR Officer | F | Ordinary Shares | 667 | $89.34 | 32,137.0000 | 1,289,900,000 | 2.03% | 0.00% |
| Aug. 1, 2025 | Walter Matthew R. | SVP, Chief HR Officer | F | Ordinary Shares | 364 | $89.34 | 31,773.0000 | 1,289,900,000 | 1.13% | 0.00% |
| Aug. 1, 2025 | Walter Matthew R. | SVP, Chief HR Officer | M | Ordinary Shares | 963 | $78.00 | 32,736.0000 | 1,289,900,000 | 3.03% | 0.00% |
| Aug. 1, 2025 | Walter Matthew R. | SVP, Chief HR Officer | F | Ordinary Shares | 879 | $89.34 | 31,857.0000 | 1,289,900,000 | 2.69% | 0.00% |
| Aug. 1, 2025 | Walter Matthew R. | SVP, Chief HR Officer | M | Performance Share Unit | 2179 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Walter Matthew R. | SVP, Chief HR Officer | M | Stock Option (Right to Buy) | 963 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Wall Brett A. | EVP & Pres Neuroscience | M | Ordinary Shares | 15249 | $0.00 | 66,531.0000 | 1,289,900,000 | 29.74% | 0.00% |
| Aug. 1, 2025 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 7744 | $89.34 | 58,787.0000 | 1,289,900,000 | 11.64% | 0.00% |
| Aug. 1, 2025 | Wall Brett A. | EVP & Pres Neuroscience | M | Performance Share Units | 15249 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | M | Ordinary Shares | 11328 | $0.00 | 83,071.0000 | 1,289,900,000 | 15.79% | 0.00% |
| Aug. 1, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 4458 | $89.34 | 78,613.0000 | 1,289,900,000 | 5.37% | 0.00% |
| Aug. 1, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 2656 | $89.34 | 75,957.0000 | 1,289,900,000 | 3.38% | 0.00% |
| Aug. 1, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | M | Performance Share Units | 11328 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Martha Geoffrey | Chairman and CEO | M | Ordinary Shares | 57724 | $0.00 | 283,700.0000 | 1,289,900,000 | 25.54% | 0.00% |
| Aug. 1, 2025 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 26323 | $89.34 | 257,377.0000 | 1,289,900,000 | 9.28% | 0.00% |
| Aug. 1, 2025 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 13054 | $89.34 | 244,323.0000 | 1,289,900,000 | 5.07% | 0.00% |
| Aug. 1, 2025 | Martha Geoffrey | Chairman and CEO | M | Ordinary Shares | 40600 | $78.00 | 284,923.0000 | 1,289,900,000 | 16.62% | 0.00% |
| Aug. 1, 2025 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 37798 | $89.34 | 247,125.0000 | 1,289,900,000 | 13.27% | 0.00% |
| Aug. 1, 2025 | Martha Geoffrey | Chairman and CEO | M | Performance Share Units | 57724 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Martha Geoffrey | Chairman and CEO | M | Stock Option (Right to Buy) | 40600 | $0.00 | 0.0000 | 1,289,900,000 | 100.00% | 0.00% |
| Aug. 1, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | M | Ordinary Shares | 6535 | $0.00 | 57,628.0000 | 1,289,900,000 | 12.79% | 0.00% |
| Aug. 1, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | Ordinary Shares | 3158 | $89.34 | 54,470.0000 | 1,289,900,000 | 5.48% | 0.00% |
| Aug. 1, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | Ordinary Shares | 1741 | $89.34 | 52,729.0000 | 1,289,900,000 | 3.20% | 0.00% |
| July 31, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 1630 | $90.24 | 71,743.0000 | 1,289,900,000 | 2.22% | 0.00% |
| July 28, 2025 | Martha Geoffrey | Chairman and CEO | A | Ordinary Shares | 37513 | $0.00 | 225,976.0000 | 1,289,900,000 | 19.90% | 0.00% |
| July 28, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 61338 | $0.00 | 61,338.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Performance Share Units | 21747 | $0.00 | 21,747.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Ordinary Shares | 8699 | $0.00 | 39,958.0000 | 1,289,900,000 | 27.83% | 0.00% |
| July 28, 2025 | Quinn Michelle | EVP, GC and Secretary | A | Stock Option (Right to Buy) | 38336 | $0.00 | 38,336.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Quinn Michelle | EVP, GC and Secretary | A | Performance Share Units | 13592 | $0.00 | 13,592.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Quinn Michelle | EVP, GC and Secretary | A | Ordinary Shares | 16310 | $0.00 | 21,747.0000 | 1,289,900,000 | 299.98% | 0.00% |
| July 28, 2025 | Quinn Michelle | EVP, GC and Secretary | A | Ordinary Shares | 5437 | $0.00 | 5,437.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Stock Option (Right to Buy) | 69005 | $0.00 | 69,005.0000 | 1,289,900,000 | 9999.99% | 0.01% |
| July 28, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Performance Share Units | 24465 | $0.00 | 24,465.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Ordinary Shares | 9786 | $0.00 | 73,373.0000 | 1,289,900,000 | 15.39% | 0.00% |
| July 28, 2025 | Wall Brett A. | EVP & Pres Neuroscience | A | Stock Option (Right to Buy) | 69005 | $0.00 | 69,005.0000 | 1,289,900,000 | 9999.99% | 0.01% |
| July 28, 2025 | Wall Brett A. | EVP & Pres Neuroscience | A | Performance Share Units | 24465 | $0.00 | 24,465.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Wall Brett A. | EVP & Pres Neuroscience | A | Ordinary Shares | 9786 | $0.00 | 51,282.0000 | 1,289,900,000 | 23.58% | 0.00% |
| July 28, 2025 | Walter Matthew R. | SVP, Chief HR Officer | A | Ordinary Shares | 4350 | $0.00 | 30,625.0000 | 1,289,900,000 | 16.56% | 0.00% |
| July 28, 2025 | Walter Matthew R. | SVP, Chief HR Officer | A | Performance Share Units | 10874 | $0.00 | 10,874.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Walter Matthew R. | SVP, Chief HR Officer | A | Stock Option (Right to Buy) | 30669 | $0.00 | 30,669.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Martha Geoffrey | Chairman and CEO | A | Stock Option (Right to Buy) | 264518 | $0.00 | 264,518.0000 | 1,289,900,000 | 9999.99% | 0.02% |
| July 28, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | A | Ordinary Shares | 9786 | $0.00 | 51,093.0000 | 1,289,900,000 | 23.69% | 0.00% |
| July 28, 2025 | Martha Geoffrey | Chairman and CEO | A | Performance Share Units | 93781 | $0.00 | 93,781.0000 | 1,289,900,000 | 9999.99% | 0.01% |
| July 28, 2025 | Blomquist Denise L. | Chief Accounting Officer | A | Stock Option (Right to Buy) | 1278 | $0.00 | 1,278.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Blomquist Denise L. | Chief Accounting Officer | A | Performance Share Units | 2202 | $0.00 | 2,202.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | Blomquist Denise L. | Chief Accounting Officer | A | Ordinary Shares | 2202 | $0.00 | 12,425.0000 | 1,289,900,000 | 21.54% | 0.00% |
| July 28, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | A | Stock Option (Right to Buy) | 53671 | $0.00 | 53,671.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | A | Performance Share Units | 19028 | $0.00 | 19,028.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| July 28, 2025 | KIIL HARRY SKIP | EVP & President Cardiovascular | A | Ordinary Shares | 7612 | $0.00 | 41,318.0000 | 1,289,900,000 | 22.58% | 0.00% |
| July 28, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | A | Stock Option (Right to Buy) | 69005 | $0.00 | 69,005.0000 | 1,289,900,000 | 9999.99% | 0.01% |
| July 28, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | A | Performance Share Units | 24465 | $0.00 | 24,465.0000 | 1,289,900,000 | 9999.99% | 0.00% |
| June 3, 2025 | Blomquist Denise L. | Chief Accounting Officer | G | Ordinary Shares | 310 | $0.00 | 10,143.0000 | 1,289,900,000 | 2.97% | 0.00% |
| May 2, 2025 | Walter Matthew R. | SVP, Chief HR Officer | F | Ordinary Shares | 34 | $84.85 | 26,054.0000 | 1,289,900,000 | 0.13% | 0.00% |
| April 29, 2025 | Fonseca Lidia | Director | F | Ordinary Shares | 216 | $84.60 | 5,675.0000 | 1,289,900,000 | 3.67% | 0.00% |
| April 28, 2025 | Blomquist Denise L. | Chief Accounting Officer | A | Ordinary Shares | 2975 | $0.00 | 10,453.0000 | 1,289,900,000 | 39.78% | 0.00% |
| April 28, 2025 | Powell Kendall J | Director | A | Ordinary Shares | 2083 | $84.04 | 48,838.0000 | 1,289,900,000 | 4.46% | 0.00% |
| April 29, 2025 | Powell Kendall J | Director | F | Ordinary Shares | 216 | $84.60 | 48,622.0000 | 1,289,900,000 | 0.44% | 0.00% |
| April 28, 2025 | NABEL ELIZABETH G | Director | A | Ordinary Shares | 2083 | $84.04 | 17,831.0000 | 1,289,900,000 | 13.23% | 0.00% |
| April 29, 2025 | NABEL ELIZABETH G | Director | F | Ordinary Shares | 216 | $84.60 | 17,615.0000 | 1,289,900,000 | 1.21% | 0.00% |
| April 28, 2025 | Lofton Kevin E | Director | A | Ordinary Shares | 2083 | $84.04 | 8,387.0000 | 1,289,900,000 | 33.04% | 0.00% |
| April 29, 2025 | Lofton Kevin E | Director | F | Ordinary Shares | 216 | $84.60 | 8,171.0000 | 1,289,900,000 | 2.58% | 0.00% |
| April 28, 2025 | Lewis Gregory P | Director | A | Ordinary Shares | 2083 | $84.04 | 3,966.0000 | 1,289,900,000 | 110.62% | 0.00% |
| April 29, 2025 | Lewis Gregory P | Director | F | Ordinary Shares | 181 | $84.60 | 3,785.0000 | 1,289,900,000 | 4.56% | 0.00% |
| April 28, 2025 | HOGAN RANDALL J | Director | A | Ordinary Shares | 2083 | $84.04 | 47,245.0000 | 1,289,900,000 | 4.61% | 0.00% |
| April 29, 2025 | HOGAN RANDALL J | Director | F | Ordinary Shares | 216 | $84.60 | 47,029.0000 | 1,289,900,000 | 0.46% | 0.00% |
| April 28, 2025 | Goldsmith Andrea Jo | Director | A | Ordinary Shares | 2083 | $84.04 | 10,463.0000 | 1,289,900,000 | 24.86% | 0.00% |
| April 29, 2025 | Goldsmith Andrea Jo | Director | F | Ordinary Shares | 216 | $84.60 | 10,247.0000 | 1,289,900,000 | 2.06% | 0.00% |
| April 28, 2025 | Fonseca Lidia | Director | A | Ordinary Shares | 2083 | $84.04 | 5,891.0000 | 1,289,900,000 | 54.70% | 0.00% |
| April 28, 2025 | DONNELLY SCOTT C | Director | A | Ordinary Shares | 2083 | $84.04 | 21,846.0000 | 1,289,900,000 | 10.54% | 0.00% |
| April 29, 2025 | DONNELLY SCOTT C | Director | F | Ordinary Shares | 216 | $84.60 | 21,630.0000 | 1,289,900,000 | 0.99% | 0.00% |
| April 28, 2025 | ARNOLD CRAIG | Director | A | Ordinary Shares | 2083 | $84.04 | 40,432.0000 | 1,289,900,000 | 5.43% | 0.00% |
| April 29, 2025 | ARNOLD CRAIG | Director | F | Ordinary Shares | 216 | $84.60 | 40,216.0000 | 1,289,900,000 | 0.53% | 0.00% |
| March 3, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Ordinary Shares | 4242 | $0.00 | 4,242.0000 | 1,292,500,000 | 9999.99% | 0.00% |
| March 3, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Ordinary Shares | 26512 | $0.00 | 30,754.0000 | 1,292,500,000 | 624.99% | 0.00% |
| March 3, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 29574 | $0.00 | 29,574.0000 | 1,292,500,000 | 9999.99% | 0.00% |
| March 3, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Ordinary Shares | 4242 | $94.30 | 4,242.0000 | 1,292,500,000 | 9999.99% | 0.00% |
| March 3, 2025 | Marinaro Michael | EVP & President, Surgical OU | F | Ordinary Shares | 575 | $94.30 | 40,675.0000 | 1,292,500,000 | 1.39% | 0.00% |
| March 3, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Performance Share Unit | 10605 | $0.00 | 10,605.0000 | 1,292,500,000 | 9999.99% | 0.00% |
| March 3, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Ordinary Shares | 26512 | $94.30 | 30,754.0000 | 1,292,500,000 | 624.99% | 0.00% |
| March 3, 2025 | Pieton Thierry | EVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 29574 | $0.00 | 29,574.0000 | 1,292,500,000 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Walter Matthew R. | SVP, Chief HR Officer | F | Ordinary Shares | 1174 | $92.46 | 25,823.0000 | 1,292,500,000 | 4.35% | 0.00% |
| Jan. 27, 2025 | Walter Matthew R. | SVP, Chief HR Officer | M | Ordinary Shares | 1337 | $74.84 | 26,997.0000 | 1,292,500,000 | 5.21% | 0.00% |
| Jan. 27, 2025 | Martha Geoffrey | Chairman and CEO | M | Stock Option (Right to Buy) | 34741 | $0.00 | 0.0000 | 1,292,500,000 | 100.00% | 0.00% |
| Jan. 27, 2025 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 30184 | $92.46 | 186,770.0000 | 1,292,500,000 | 13.91% | 0.00% |
| Jan. 27, 2025 | Martha Geoffrey | Chairman and CEO | M | Ordinary Shares | 34741 | $74.84 | 216,954.0000 | 1,292,500,000 | 19.07% | 0.00% |
| Jan. 27, 2025 | Marinaro Michael | EVP & President, Surgical OU | M | Stock Option (Right to Buy) | 2345 | $0.00 | 0.0000 | 1,292,500,000 | 100.00% | 0.00% |
| Jan. 27, 2025 | Marinaro Michael | EVP & President, Surgical OU | F | Ordinary Shares | 2073 | $92.46 | 41,250.0000 | 1,292,500,000 | 4.78% | 0.00% |
| Jan. 27, 2025 | Marinaro Michael | EVP & President, Surgical OU | M | Ordinary Shares | 2345 | $74.84 | 43,323.0000 | 1,292,500,000 | 5.72% | 0.00% |
| Jan. 27, 2025 | Walter Matthew R. | SVP, Chief HR Officer | M | Stock Option (Right to Buy) | 1337 | $0.00 | 0.0000 | 1,292,500,000 | 100.00% | 0.00% |
| Jan. 24, 2025 | Wall Brett A. | EVP & Pres Neuroscience | M | Ordinary Shares | 12437 | $78.00 | 53,416.0000 | 1,292,500,000 | 30.35% | 0.00% |
| Jan. 24, 2025 | Wall Brett A. | EVP & Pres Neuroscience | M | Stock Option (Right to Buy) | 12437 | $0.00 | 0.0000 | 1,292,500,000 | 100.00% | 0.00% |
| Jan. 24, 2025 | Wall Brett A. | EVP & Pres Neuroscience | S | Ordinary Shares | 12437 | $90.00 | 40,979.0000 | 1,292,500,000 | 23.28% | 0.00% |
| Jan. 21, 2025 | Corona Gary Louis | Interim CFO | A | Ordinary Shares | 11315 | $0.00 | 44,255.0000 | 1,292,500,000 | 34.35% | 0.00% |
| Jan. 8, 2025 | Wall Brett A. | EVP & Pres Neuroscience | M | Ordinary Shares | 6850 | $74.84 | 50,558.0000 | 1,292,500,000 | 15.67% | 0.00% |
| Jan. 8, 2025 | Wall Brett A. | EVP & Pres Neuroscience | M | Stock Option (Right to Buy) | 6850 | $0.00 | 0.0000 | 1,292,500,000 | 100.00% | 0.00% |
| Jan. 8, 2025 | Wall Brett A. | EVP & Pres Neuroscience | S | Ordinary Shares | 3000 | $80.41 | 40,708.0000 | 1,292,500,000 | 6.86% | 0.00% |
| Jan. 8, 2025 | Wall Brett A. | EVP & Pres Neuroscience | S | Ordinary Shares | 6850 | $80.41 | 43,708.0000 | 1,292,500,000 | 13.55% | 0.00% |
| Dec. 16, 2024 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 645 | $82.48 | 43,708.0000 | 1,292,500,000 | 1.45% | 0.00% |
| Dec. 16, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | F | Ordinary Shares | 532 | $82.48 | 54,692.0000 | 1,292,500,000 | 0.96% | 0.00% |
| Dec. 16, 2024 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 4417 | $82.48 | 181,326.0000 | 1,292,500,000 | 2.38% | 0.00% |
| Dec. 16, 2024 | Salmon Sean | EVP & President Cardiovascular | F | Ordinary Shares | 645 | $82.48 | 64,722.0000 | 1,292,500,000 | 0.99% | 0.00% |
| Dec. 10, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | F | Ordinary Shares | 3009 | $83.58 | 55,224.0000 | 1,292,500,000 | 5.17% | 0.00% |
| Dec. 6, 2024 | Kirk Jennifer M | Chief Accounting Officer | F | Ordinary Shares | 646 | $84.01 | 28,011.0000 | 1,292,500,000 | 2.25% | 0.00% |
| Dec. 6, 2024 | Corona Gary Louis | Interim CFO | F | Ordinary Shares | 662 | $84.01 | 32,721.0000 | 1,292,500,000 | 1.98% | 0.00% |
| Aug. 20, 2024 | Marinaro Michael | EVP & President, Surgical OU | F | Ordinary Shares | 2045 | $85.38 | 40,346.0000 | 1,330,200,000 | 4.82% | 0.00% |
| Aug. 15, 2024 | Corona Gary Louis | Interim CFO | A | Ordinary Shares | 8966 | $0.00 | 33,035.0000 | 1,330,200,000 | 37.25% | 0.00% |
| Aug. 2, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | M | Ordinary Shares | 6144 | $0.00 | 63,750.0000 | 1,330,200,000 | 10.67% | 0.00% |
| Aug. 2, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | F | Ordinary Shares | 2802 | $81.51 | 60,948.0000 | 1,330,200,000 | 4.40% | 0.00% |
| Aug. 2, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | F | Ordinary Shares | 2985 | $81.51 | 57,963.0000 | 1,330,200,000 | 4.90% | 0.00% |
| Aug. 2, 2024 | Wall Brett A. | EVP & Pres Neuroscience | M | Ordinary Shares | 5311 | $0.00 | 49,169.0000 | 1,330,200,000 | 12.11% | 0.00% |
| Aug. 2, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | M | Performance Share Units | 6144 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | M | Performance Share Units | 8370 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 2362 | $81.51 | 46,807.0000 | 1,330,200,000 | 4.80% | 0.00% |
| Aug. 2, 2024 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 2701 | $81.51 | 44,106.0000 | 1,330,200,000 | 5.77% | 0.00% |
| Aug. 2, 2024 | Wall Brett A. | EVP & Pres Neuroscience | M | Performance Share Units | 5311 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Walter Matthew R. | SVP, Chief HR Officer | M | Ordinary Shares | 684 | $0.00 | 25,889.0000 | 1,330,200,000 | 2.71% | 0.00% |
| Aug. 2, 2024 | Walter Matthew R. | SVP, Chief HR Officer | F | Ordinary Shares | 210 | $81.51 | 25,679.0000 | 1,330,200,000 | 0.81% | 0.00% |
| Aug. 2, 2024 | Walter Matthew R. | SVP, Chief HR Officer | F | Ordinary Shares | 231 | $81.51 | 25,448.0000 | 1,330,200,000 | 0.90% | 0.00% |
| Aug. 2, 2024 | Walter Matthew R. | SVP, Chief HR Officer | M | Performance Share Unit | 684 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | M | Ordinary Shares | 3490 | $0.00 | 64,757.0000 | 1,330,200,000 | 5.70% | 0.00% |
| Aug. 2, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 1374 | $81.51 | 63,383.0000 | 1,330,200,000 | 2.12% | 0.00% |
| Aug. 2, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 1513 | $81.51 | 61,870.0000 | 1,330,200,000 | 2.39% | 0.00% |
| Aug. 2, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | M | Performance Share Units | 3490 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Ordinary Shares | 5462 | $0.00 | 68,546.0000 | 1,330,200,000 | 8.66% | 0.00% |
| Aug. 2, 2024 | Salmon Sean | EVP & President Cardiovascular | F | Ordinary Shares | 657 | $81.51 | 67,889.0000 | 1,330,200,000 | 0.96% | 0.00% |
| Aug. 2, 2024 | Salmon Sean | EVP & President Cardiovascular | F | Ordinary Shares | 2779 | $81.51 | 65,110.0000 | 1,330,200,000 | 4.09% | 0.00% |
| Aug. 2, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Performance Share Units | 5462 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | PARKHILL KAREN L | EVP & Chief Financial Officer | M | Ordinary Shares | 7132 | $0.00 | 105,847.0000 | 1,330,200,000 | 7.22% | 0.00% |
| Aug. 2, 2024 | PARKHILL KAREN L | EVP & Chief Financial Officer | F | Ordinary Shares | 3148 | $81.51 | 102,699.0000 | 1,330,200,000 | 2.97% | 0.00% |
| Aug. 2, 2024 | PARKHILL KAREN L | EVP & Chief Financial Officer | F | Ordinary Shares | 3581 | $81.51 | 99,118.0000 | 1,330,200,000 | 3.49% | 0.00% |
| Aug. 2, 2024 | PARKHILL KAREN L | EVP & Chief Financial Officer | M | Performance Share Units | 7132 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Martha Geoffrey | Chairman and CEO | M | Ordinary Shares | 18966 | $0.00 | 203,086.0000 | 1,330,200,000 | 10.30% | 0.00% |
| Aug. 2, 2024 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 8649 | $81.51 | 194,437.0000 | 1,330,200,000 | 4.26% | 0.00% |
| Aug. 2, 2024 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 9523 | $81.51 | 184,914.0000 | 1,330,200,000 | 4.90% | 0.00% |
| Aug. 2, 2024 | Martha Geoffrey | Chairman and CEO | M | Performance Share Units | 18966 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Marinaro Michael | EVP & President, Surgical OU | M | Ordinary Shares | 1670 | $0.00 | 43,801.0000 | 1,330,200,000 | 3.96% | 0.00% |
| Aug. 2, 2024 | Marinaro Michael | EVP & President, Surgical OU | F | Ordinary Shares | 563 | $81.51 | 43,238.0000 | 1,330,200,000 | 1.29% | 0.00% |
| Aug. 2, 2024 | Marinaro Michael | EVP & President, Surgical OU | F | Ordinary Shares | 847 | $81.51 | 42,391.0000 | 1,330,200,000 | 1.96% | 0.00% |
| Aug. 2, 2024 | Marinaro Michael | EVP & President, Surgical OU | M | Performance Share Unit | 1670 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Kirk Jennifer M | Chief Accounting Officer | M | Ordinary Shares | 1138 | $0.00 | 28,980.0000 | 1,330,200,000 | 4.09% | 0.00% |
| Aug. 2, 2024 | Kirk Jennifer M | Chief Accounting Officer | F | Ordinary Shares | 92 | $81.51 | 28,888.0000 | 1,330,200,000 | 0.32% | 0.00% |
| Aug. 2, 2024 | Kirk Jennifer M | Chief Accounting Officer | F | Ordinary Shares | 384 | $81.51 | 28,504.0000 | 1,330,200,000 | 1.33% | 0.00% |
| Aug. 2, 2024 | Kirk Jennifer M | Chief Accounting Officer | M | Performance Share Units | 1138 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| Aug. 2, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | M | Ordinary Shares | 8370 | $0.00 | 61,029.0000 | 1,330,200,000 | 15.89% | 0.00% |
| Aug. 2, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | F | Ordinary Shares | 3423 | $81.51 | 57,606.0000 | 1,330,200,000 | 5.61% | 0.00% |
| July 31, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 1406 | $80.32 | 61,267.0000 | 1,330,200,000 | 2.24% | 0.00% |
| July 29, 2024 | Marinaro Michael | EVP & President, Surgical OU | M | Performance Share Unit | 34375 | $0.00 | 34,375.0000 | 1,330,200,000 | 50.00% | 0.00% |
| July 29, 2024 | Walter Matthew R. | SVP, Chief HR Officer | A | Ordinary Shares | 7625 | $0.00 | 25,205.0000 | 1,330,200,000 | 43.37% | 0.00% |
| July 29, 2024 | Walter Matthew R. | SVP, Chief HR Officer | A | Performance Share Unit | 19063 | $0.00 | 19,063.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Walter Matthew R. | SVP, Chief HR Officer | A | Stock Option (Right to Buy) | 56364 | $0.00 | 56,364.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Wall Brett A. | EVP & Pres Neuroscience | A | Ordinary Shares | 14375 | $0.00 | 43,858.0000 | 1,330,200,000 | 48.76% | 0.00% |
| July 29, 2024 | Wall Brett A. | EVP & Pres Neuroscience | A | Performance Share Unit | 35938 | $0.00 | 35,938.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Wall Brett A. | EVP & Pres Neuroscience | A | Stock Option (Right to Buy) | 106260 | $0.00 | 106,260.0000 | 1,330,200,000 | 9999.99% | 0.01% |
| July 29, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Ordinary Shares | 14375 | $0.00 | 62,673.0000 | 1,330,200,000 | 29.76% | 0.00% |
| July 29, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Performance Share Unit | 35938 | $0.00 | 35,938.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Stock Option (Right to Buy) | 106260 | $0.00 | 106,260.0000 | 1,330,200,000 | 9999.99% | 0.01% |
| July 29, 2024 | Salmon Sean | EVP & President Cardiovascular | A | Ordinary Shares | 14375 | $0.00 | 63,084.0000 | 1,330,200,000 | 29.51% | 0.00% |
| July 29, 2024 | Salmon Sean | EVP & President Cardiovascular | A | Performance Share Unit | 35938 | $0.00 | 35,938.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Salmon Sean | EVP & President Cardiovascular | A | Stock Option (Right to Buy) | 106260 | $0.00 | 106,260.0000 | 1,330,200,000 | 9999.99% | 0.01% |
| July 29, 2024 | Martha Geoffrey | Chairman and CEO | A | Ordinary Shares | 40000 | $0.00 | 184,120.0000 | 1,330,200,000 | 27.75% | 0.00% |
| July 29, 2024 | Martha Geoffrey | Chairman and CEO | A | Performance Share Unit | 100000 | $0.00 | 100,000.0000 | 1,330,200,000 | 9999.99% | 0.01% |
| July 29, 2024 | Martha Geoffrey | Chairman and CEO | A | Stock Option (Right to Buy) | 295680 | $0.00 | 295,680.0000 | 1,330,200,000 | 9999.99% | 0.02% |
| July 29, 2024 | Marinaro Michael | EVP & President, Surgical OU | A | Ordinary Shares | 13750 | $0.00 | 42,131.0000 | 1,330,200,000 | 48.45% | 0.00% |
| July 29, 2024 | Marinaro Michael | EVP & President, Surgical OU | A | Stock Option (Right to Buy) | 101640 | $0.00 | 101,640.0000 | 1,330,200,000 | 9999.99% | 0.01% |
| July 29, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A | Ordinary Shares | 12750 | $0.00 | 52,659.0000 | 1,330,200,000 | 31.95% | 0.00% |
| July 29, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A | Performance Share Unit | 31875 | $0.00 | 31,875.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A | Stock Option (Right to Buy) | 94248 | $0.00 | 92,248.0000 | 1,330,200,000 | 0.00% | 0.01% |
| July 29, 2024 | Kirk Jennifer M | Chief Accounting Officer | A | Ordinary Shares | 7813 | $0.00 | 21,516.0000 | 1,330,200,000 | 57.02% | 0.00% |
| July 29, 2024 | Kirk Jennifer M | Chief Accounting Officer | A | Ordinary Shares | 6326 | $0.00 | 27,842.0000 | 1,330,200,000 | 29.40% | 0.00% |
| July 29, 2024 | Kirk Jennifer M | Chief Accounting Officer | A | Performance Share Unit | 7813 | $0.00 | 7,813.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Kirk Jennifer M | Chief Accounting Officer | A | Performance Share Unit | 3125 | $0.00 | 3,125.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 29, 2024 | Kirk Jennifer M | Chief Accounting Officer | A | Stock Option (Right to Buy) | 1540 | $0.00 | 1,540.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| July 18, 2024 | Walter Matthew R. | SVP, Chief HR Officer | M | Ordinary Shares | 492 | $62.76 | 17,580.0000 | 1,330,200,000 | 2.88% | 0.00% |
| July 18, 2024 | Walter Matthew R. | SVP, Chief HR Officer | M | Stock Option (Right to Buy) | 492 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| June 7, 2024 | Martha Geoffrey | Chairman and CEO | M | Stock Option (Right to Buy) | 17519 | $0.00 | 1,594.0000 | 1,330,200,000 | 91.66% | 0.00% |
| June 7, 2024 | Martha Geoffrey | Chairman and CEO | S | Ordinary Shares | 17519 | $83.76 | 144,942.0000 | 1,330,200,000 | 10.78% | 0.00% |
| June 7, 2024 | Martha Geoffrey | Chairman and CEO | M | Ordinary Shares | 17519 | $62.76 | 160,867.0000 | 1,330,200,000 | 12.22% | 0.00% |
| June 7, 2024 | Martha Geoffrey | Chairman and CEO | M | Ordinary Shares | 1594 | $62.76 | 162,461.0000 | 1,330,200,000 | 0.99% | 0.00% |
| June 7, 2024 | Martha Geoffrey | Chairman and CEO | S | Ordinary Shares | 1594 | $83.82 | 143,348.0000 | 1,330,200,000 | 1.10% | 0.00% |
| June 7, 2024 | Martha Geoffrey | Chairman and CEO | M | Stock Option (Right to Buy) | 1594 | $0.00 | 0.0000 | 1,330,200,000 | 100.00% | 0.00% |
| May 1, 2024 | Goldsmith Andrea Jo | Director | F | Ordinary Shares | 192 | $80.89 | 8,306.0000 | 1,330,200,000 | 2.26% | 0.00% |
| May 1, 2024 | HOGAN RANDALL J | Director | F | Ordinary Shares | 192 | $80.89 | 45,088.0000 | 1,330,200,000 | 0.42% | 0.00% |
| May 1, 2024 | Lofton Kevin E | Director | F | Ordinary Shares | 192 | $80.89 | 6,230.0000 | 1,330,200,000 | 2.99% | 0.00% |
| May 1, 2024 | NABEL ELIZABETH G | Director | F | Ordinary Shares | 192 | $80.89 | 15,674.0000 | 1,330,200,000 | 1.21% | 0.00% |
| May 1, 2024 | OLEARY DENISE M | Director | F | Ordinary Shares | 192 | $80.89 | 77,057.0000 | 1,330,200,000 | 0.25% | 0.00% |
| May 1, 2024 | Powell Kendall J | Director | F | Ordinary Shares | 192 | $80.89 | 45,843.0000 | 1,330,200,000 | 0.42% | 0.00% |
| May 1, 2024 | ARNOLD CRAIG | Director | F | Ordinary Shares | 192 | $80.89 | 38,275.0000 | 1,330,200,000 | 0.50% | 0.00% |
| May 1, 2024 | DONNELLY SCOTT C | Director | F | Ordinary Shares | 192 | $80.89 | 19,604.0000 | 1,330,200,000 | 0.97% | 0.00% |
| May 1, 2024 | Fonseca Lidia | Director | F | Ordinary Shares | 162 | $80.89 | 3,682.0000 | 1,330,200,000 | 4.21% | 0.00% |
| April 29, 2024 | Lofton Kevin E | Director | A | Ordinary Shares | 2165 | $80.86 | 6,422.0000 | 1,330,200,000 | 50.86% | 0.00% |
| April 29, 2024 | ARNOLD CRAIG | Director | A | Ordinary Shares | 2165 | $80.86 | 38,467.0000 | 1,330,200,000 | 5.96% | 0.00% |
| April 29, 2024 | DONNELLY SCOTT C | Director | A | Ordinary Shares | 2165 | $80.86 | 19,796.0000 | 1,330,200,000 | 12.28% | 0.00% |
| April 29, 2024 | Fonseca Lidia | Director | A | Ordinary Shares | 2165 | $80.86 | 3,844.0000 | 1,330,200,000 | 128.95% | 0.00% |
| April 29, 2024 | Goldsmith Andrea Jo | Director | A | Ordinary Shares | 2165 | $80.86 | 8,498.0000 | 1,330,200,000 | 34.19% | 0.00% |
| April 29, 2024 | HOGAN RANDALL J | Director | A | Ordinary Shares | 2165 | $80.86 | 45,280.0000 | 1,330,200,000 | 5.02% | 0.00% |
| April 29, 2024 | Powell Kendall J | Director | A | Ordinary Shares | 2165 | $80.86 | 46,035.0000 | 1,330,200,000 | 4.94% | 0.00% |
| April 29, 2024 | OLEARY DENISE M | Director | A | Ordinary Shares | 2165 | $80.86 | 77,249.0000 | 1,330,200,000 | 2.88% | 0.00% |
| April 29, 2024 | NABEL ELIZABETH G | Director | A | Ordinary Shares | 2165 | $80.86 | 15,866.0000 | 1,330,200,000 | 15.80% | 0.00% |
| April 29, 2024 | Lewis Gregory P | Director | A | Ordinary Shares | 1821 | $80.86 | 1,821.0000 | 1,330,200,000 | 9999.99% | 0.00% |
| April 8, 2024 | Marinaro Michael | EVP & President, Surgical OU | S | Ordinary Shares | 854 | $83.14 | 27,925.0000 | 1,332,800,000 | 2.97% | 0.00% |
| March 5, 2024 | Marinaro Michael | EVP & President, Surgical OU | F | Ordinary Shares | 563 | $83.60 | 28,779.0000 | 1,332,800,000 | 1.92% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | S | Ordinary Shares | 1594 | $85.06 | 77,390.0000 | 1,332,800,000 | 2.02% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | S | Ordinary Shares | 13066 | $85.15 | 64,324.0000 | 1,332,800,000 | 16.88% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Stock Option (Right to Buy) | 16035 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Stock Option (Right to Buy) | 13066 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Stock Option (Right to Buy) | 1594 | $0.00 | 13,066.0000 | 1,332,800,000 | 10.87% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | S | Ordinary Shares | 16035 | $85.12 | 48,289.0000 | 1,332,800,000 | 24.93% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Ordinary Shares | 1594 | $62.76 | 49,833.0000 | 1,332,800,000 | 3.30% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Ordinary Shares | 16035 | $74.84 | 78,984.0000 | 1,332,800,000 | 25.47% | 0.00% |
| Feb. 21, 2024 | Salmon Sean | EVP & President Cardiovascular | M | Ordinary Shares | 13066 | $62.76 | 62,949.0000 | 1,332,800,000 | 26.19% | 0.00% |
| Feb. 1, 2024 | Kirk Jennifer M | Chief Accounting Officer | F | Ordinary Shares | 1159 | $88.09 | 13,208.0000 | 1,332,800,000 | 8.07% | 0.00% |
| Dec. 19, 2023 | Wall Brett A. | EVP & Pres Neuroscience | S | Ordinary Shares | 4997 | $82.17 | 28,910.0000 | 1,332,800,000 | 14.74% | 0.00% |
| Dec. 8, 2023 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | F | Ordinary Shares | 369 | $79.27 | 49,910.0000 | 1,332,800,000 | 0.73% | 0.00% |
| Dec. 8, 2023 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 435 | $79.27 | 33,907.0000 | 1,332,800,000 | 1.27% | 0.00% |
| Dec. 8, 2023 | Salmon Sean | EVP & President Cardiovascular | F | Ordinary Shares | 435 | $79.27 | 48,103.0000 | 1,332,800,000 | 0.90% | 0.00% |
| Dec. 8, 2023 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | F | Ordinary Shares | 716 | $79.27 | 40,091.0000 | 1,332,800,000 | 1.75% | 0.00% |
| Dec. 11, 2023 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | F | Ordinary Shares | 1952 | $79.35 | 39,201.0000 | 1,332,800,000 | 4.74% | 0.00% |
| Oct. 30, 2023 | Kirk Jennifer M | Chief Accounting Officer | A | Stock Option (Right to Buy) | 1695 | $0.00 | 1,695.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| Aug. 23, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | S | Ordinary Shares | 10000 | $83.84 | 46,723.0000 | 1,332,800,000 | 17.63% | 0.00% |
| Aug. 14, 2023 | Wall Brett A. | EVP & Pres Neuroscience | S | Ordinary Shares | 1000 | $83.38 | 33,573.0000 | 1,332,800,000 | 2.89% | 0.00% |
| Aug. 3, 2023 | PARKHILL KAREN L | EVP & Chief Financial Officer | A | Ordinary Shares | 7105 | $0.00 | 104,634.0000 | 1,332,800,000 | 7.29% | 0.00% |
| Aug. 3, 2023 | PARKHILL KAREN L | EVP & Chief Financial Officer | F | Ordinary Shares | 5919 | $84.49 | 98,715.0000 | 1,332,800,000 | 5.66% | 0.00% |
| Aug. 3, 2023 | PARKHILL KAREN L | EVP & Chief Financial Officer | M | Performance Share Units | 7105 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | Martha Geoffrey | Chairman and CEO | A | Ordinary Shares | 18165 | $0.00 | 159,109.0000 | 1,332,800,000 | 12.89% | 0.00% |
| Aug. 3, 2023 | Martha Geoffrey | Chairman and CEO | F | Ordinary Shares | 17965 | $84.49 | 141,144.0000 | 1,332,800,000 | 11.29% | 0.00% |
| Aug. 3, 2023 | Martha Geoffrey | Chairman and CEO | M | Performance Share Units | 18165 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | F | Ordinary Shares | 4051 | $84.49 | 52,748.0000 | 1,332,800,000 | 7.13% | 0.00% |
| Aug. 3, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | M | Performance Share Units | 4251 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Ordinary Shares | 6217 | $0.00 | 61,416.0000 | 1,332,800,000 | 11.26% | 0.00% |
| Aug. 3, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 4693 | $84.49 | 56,723.0000 | 1,332,800,000 | 7.64% | 0.00% |
| Aug. 3, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | M | Performance Share Units | 6217 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | Salmon Sean | EVP & President Cardiovascular | A | Ordinary Shares | 5604 | $0.00 | 52,095.0000 | 1,332,800,000 | 12.05% | 0.00% |
| Aug. 3, 2023 | Salmon Sean | EVP & President Cardiovascular | F | Ordinary Shares | 4369 | $84.49 | 47,726.0000 | 1,332,800,000 | 8.39% | 0.00% |
| Aug. 3, 2023 | Salmon Sean | EVP & President Cardiovascular | M | Performance Share Units | 5604 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | A | Ordinary Shares | 4251 | $0.00 | 56,799.0000 | 1,332,800,000 | 8.09% | 0.00% |
| Aug. 3, 2023 | Wall Brett A. | EVP & Pres Neuroscience | M | Performance Share Units | 5168 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | Wall Brett A. | EVP & Pres Neuroscience | F | Ordinary Shares | 4284 | $84.49 | 34,573.0000 | 1,332,800,000 | 11.03% | 0.00% |
| Aug. 3, 2023 | Wall Brett A. | EVP & Pres Neuroscience | A | Ordinary Shares | 5168 | $0.00 | 38,857.0000 | 1,332,800,000 | 15.34% | 0.00% |
| Aug. 3, 2023 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | M | Performance Share Units | 5813 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | F | Ordinary Shares | 4065 | $84.49 | 49,465.0000 | 1,332,800,000 | 7.59% | 0.00% |
| Aug. 3, 2023 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A | Ordinary Shares | 5813 | $0.00 | 53,530.0000 | 1,332,800,000 | 12.18% | 0.00% |
| Aug. 3, 2023 | Kirk Jennifer M | Chief Accounting Officer | M | Performance Share Units | 1178 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 3, 2023 | Kirk Jennifer M | Chief Accounting Officer | F | Ordinary Shares | 361 | $84.49 | 14,193.0000 | 1,332,800,000 | 2.48% | 0.00% |
| Aug. 3, 2023 | Kirk Jennifer M | Chief Accounting Officer | A | Ordinary Shares | 1178 | $0.00 | 14,554.0000 | 1,332,800,000 | 8.81% | 0.00% |
| Aug. 3, 2023 | Marinaro Michael | EVP & President, Surgical OU | M | Performance Share Unit | 1696 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| Aug. 4, 2023 | Marinaro Michael | EVP & President, Surgical OU | S | Ordinary Shares | 1352 | $84.11 | 28,930.0000 | 1,332,800,000 | 4.46% | 0.00% |
| Aug. 3, 2023 | Marinaro Michael | EVP & President, Surgical OU | F | Ordinary Shares | 1323 | $84.49 | 30,282.0000 | 1,332,800,000 | 4.19% | 0.00% |
| Aug. 3, 2023 | Marinaro Michael | EVP & President, Surgical OU | A | Ordinary Shares | 1696 | $0.00 | 31,605.0000 | 1,332,800,000 | 5.67% | 0.00% |
| July 31, 2023 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A | Performance Share Units | 19941 | $0.00 | 19,941.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A | Stock Option (Right to Buy) | 56162 | $0.00 | 56,162.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | PARKHILL KAREN L | EVP & Chief Financial Officer | A | Ordinary Shares | 12535 | $0.00 | 96,806.0000 | 1,332,800,000 | 14.87% | 0.00% |
| July 31, 2023 | PARKHILL KAREN L | EVP & Chief Financial Officer | A | Performance Share Units | 31336 | $0.00 | 31,336.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | PARKHILL KAREN L | EVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 88254 | $0.00 | 88,254.0000 | 1,332,800,000 | 9999.99% | 0.01% |
| July 31, 2023 | Martha Geoffrey | Chairman and CEO | A | Ordinary Shares | 34185 | $0.00 | 139,097.0000 | 1,332,800,000 | 32.58% | 0.00% |
| July 31, 2023 | Martha Geoffrey | Chairman and CEO | A | Performance Share Units | 85461 | $0.00 | 85,461.0000 | 1,332,800,000 | 9999.99% | 0.01% |
| July 31, 2023 | Martha Geoffrey | Chairman and CEO | A | Stock Option (Right to Buy) | 240691 | $0.00 | 481,382.0000 | 1,332,800,000 | 100.00% | 0.02% |
| July 31, 2023 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A | Stock Option (Right to Buy) | 64185 | $0.00 | 64,185.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A | Performance Share Units | 22790 | $0.00 | 22,790.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A | Ordinary Shares | 9116 | $0.00 | 46,156.0000 | 1,332,800,000 | 24.61% | 0.00% |
| July 31, 2023 | Kirk Jennifer M | Chief Accounting Officer | A | Stock Option (Right to Buy) | 20058 | $0.00 | 20,058.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Kirk Jennifer M | Chief Accounting Officer | A | Performance Share Units | 7122 | $0.00 | 7,122.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Kirk Jennifer M | Chief Accounting Officer | A | Ordinary Shares | 2849 | $0.00 | 13,376.0000 | 1,332,800,000 | 27.06% | 0.00% |
| July 31, 2023 | Wall Brett A. | EVP & Pres Neuroscience | A | Performance Share Units | 24214 | $0.00 | 24,214.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Wall Brett A. | EVP & Pres Neuroscience | A | Ordinary Shares | 9686 | $0.00 | 33,634.0000 | 1,332,800,000 | 40.45% | 0.00% |
| July 31, 2023 | Wall Brett A. | EVP & Pres Neuroscience | M | Stock Option (Right to Buy) | 68196 | $0.00 | 68,196.0000 | 1,332,800,000 | 9999.99% | 0.01% |
| July 31, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | A | Ordinary Shares | 8547 | $0.00 | 52,499.0000 | 1,332,800,000 | 19.45% | 0.00% |
| July 31, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | A | Performance Share Units | 21366 | $0.00 | 21,366.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | A | Stock Option (Right to Buy) | 60173 | $0.00 | 60,173.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Ordinary Shares | 26209 | $0.00 | 55,167.0000 | 1,332,800,000 | 90.51% | 0.00% |
| July 31, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Performance Share Units | 22790 | $0.00 | 22,790.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | A | Stock Option (Right to Buy) | 64185 | $0.00 | 64,185.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Salmon Sean | EVP & President Cardiovascular | A | Ordinary Shares | 9686 | $0.00 | 46,290.0000 | 1,332,800,000 | 26.46% | 0.00% |
| July 31, 2023 | Salmon Sean | EVP & President Cardiovascular | A | Performance Share Units | 21214 | $0.00 | 21,214.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Salmon Sean | EVP & President Cardiovascular | A | Stock Option (Right to Buy) | 68196 | $0.00 | 68,196.0000 | 1,332,800,000 | 9999.99% | 0.01% |
| July 31, 2023 | Marinaro Michael | EVP & President, Surgical OU | A | Ordinary Shares | 6837 | $0.00 | 29,890.0000 | 1,332,800,000 | 29.66% | 0.00% |
| July 31, 2023 | Marinaro Michael | EVP & President, Surgical OU | A | Performance Share Units | 17093 | $0.00 | 17,093.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Marinaro Michael | EVP & President, Surgical OU | A | Stock Option (Right to Buy) | 48139 | $0.00 | 48,139.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| July 31, 2023 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A | Ordinary Shares | 7977 | $0.00 | 40,807.0000 | 1,332,800,000 | 24.30% | 0.00% |
| July 14, 2023 | Wall Brett A. | EVP & Pres Neuroscience | S | Ordinary Shares | 2000 | $87.97 | 23,948.0000 | 1,332,800,000 | 7.71% | 0.00% |
| July 10, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | M | Ordinary Shares | 1808 | $55.32 | 45,610.0000 | 1,332,800,000 | 4.13% | 0.00% |
| July 10, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | M | Ordinary Shares | 3706 | $55.32 | 47,508.0000 | 1,332,800,000 | 8.46% | 0.00% |
| July 10, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | M | Stock Option (Right to Buy) | 3706 | $0.00 | 0.0000 | 1,332,800,000 | 100.00% | 0.00% |
| July 10, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | M | Stock Option (Right to Buy) | 1808 | $0.00 | 3,706.0000 | 1,332,800,000 | 32.79% | 0.00% |
| July 10, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | S | Ordinary Shares | 3706 | $86.58 | 43,802.0000 | 1,332,800,000 | 7.80% | 0.00% |
| July 10, 2023 | TEN HOEDT ROB | EVP and Pres. Global Regions | S | Ordinary Shares | 1808 | $86.59 | 43,802.0000 | 1,332,800,000 | 3.96% | 0.00% |
| May 2, 2023 | Goldsmith Andrea Jo | Director | F | Ordinary Shares | 169 | $90.23 | 6,267.0000 | 1,332,800,000 | 2.63% | 0.00% |
| May 2, 2023 | ANDERSON RICHARD H | Director | F | Ordinary Shares | 169 | $90.23 | 120,303.0000 | 1,332,800,000 | 0.14% | 0.00% |
| May 1, 2023 | NABEL ELIZABETH G | Director | A | Ordinary Shares | 1930 | $90.68 | 13,804.0000 | 1,332,800,000 | 16.25% | 0.00% |
| May 2, 2023 | NABEL ELIZABETH G | Director | F | Ordinary Shares | 169 | $90.23 | 13,635.0000 | 1,332,800,000 | 1.22% | 0.00% |
| May 1, 2023 | HOGAN RANDALL J | Director | A | Ordinary Shares | 1930 | $90.68 | 43,217.0000 | 1,332,800,000 | 4.67% | 0.00% |
| May 2, 2023 | HOGAN RANDALL J | Director | F | Ordinary Shares | 169 | $90.23 | 43,048.0000 | 1,332,800,000 | 0.39% | 0.00% |
| May 1, 2023 | Goldsmith Andrea Jo | Director | A | Ordinary Shares | 1930 | $90.68 | 6,436.0000 | 1,332,800,000 | 42.83% | 0.00% |
| May 1, 2023 | ANDERSON RICHARD H | Director | A | Ordinary Shares | 1930 | $90.68 | 120,472.0000 | 1,332,800,000 | 1.63% | 0.00% |
| May 1, 2023 | OLEARY DENISE M | Director | A | Ordinary Shares | 1930 | $90.68 | 74,007.0000 | 1,332,800,000 | 2.68% | 0.00% |
| May 2, 2023 | OLEARY DENISE M | Director | F | Ordinary Shares | 169 | $90.23 | 73,838.0000 | 1,332,800,000 | 0.23% | 0.00% |
| May 1, 2023 | Powell Kendall J | Director | A | Ordinary Shares | 1930 | $90.68 | 43,161.0000 | 1,332,800,000 | 4.68% | 0.00% |
| May 2, 2023 | Powell Kendall J | Director | F | Ordinary Shares | 169 | $90.23 | 42,992.0000 | 1,332,800,000 | 0.39% | 0.00% |
| May 1, 2023 | Lofton Kevin E | Director | A | Ordinary Shares | 1930 | $90.68 | 4,360.0000 | 1,332,800,000 | 79.42% | 0.00% |
| May 2, 2023 | Lofton Kevin E | Director | F | Ordinary Shares | 169 | $90.23 | 4,191.0000 | 1,332,800,000 | 3.88% | 0.00% |
| May 1, 2023 | Fonseca Lidia | Director | A | Ordinary Shares | 1624 | $90.68 | 1,624.0000 | 1,332,800,000 | 9999.99% | 0.00% |
| May 1, 2023 | DONNELLY SCOTT C | Director | A | Ordinary Shares | 1930 | $90.68 | 16,745.0000 | 1,332,800,000 | 13.03% | 0.00% |
| May 2, 2023 | DONNELLY SCOTT C | Director | F | Ordinary Shares | 169 | $90.23 | 16,576.0000 | 1,332,800,000 | 1.01% | 0.00% |
| May 1, 2023 | ARNOLD CRAIG | Director | A | Ordinary Shares | 1930 | $90.68 | 36,405.0000 | 1,332,800,000 | 5.60% | 0.00% |
| May 2, 2023 | ARNOLD CRAIG | Director | F | Ordinary Shares | 169 | $90.23 | 36,236.0000 | 1,332,800,000 | 0.46% | 0.00% |
| April 18, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 74 | $80.71 | 28,882.0000 | 0 | 0.26% | 0.00% |
| April 5, 2023 | Smith Gregory L | EVP Global Ops & Supply Chain | F | Ordinary Shares | 6866 | $80.27 | 28,579.0000 | 0 | 19.37% | 0.00% |
| Feb. 1, 2023 | Kirk Jennifer M | Chief Accounting Officer | F | Ordinary Shares | 672 | $85.77 | 10,115.0000 | 0 | 6.23% | 0.00% |
| Jan. 30, 2023 | Medtronic plc | TenPercentOwner | P | Common Stock | 6835 | $9.28 | 4,999,423.0000 | 0 | 0.14% | 0.00% |